Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | UNK | — |
inappropriate preparation of medication; inappropriate dose of vaccine administered.; This non-serious case was reported by a consumer and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: inappropriate preparation of medication) and inappropriate dose of vaccine administered (Verbatim: inappropriate dose of vaccine administered.). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 30-APR-2025 The reporter was the Clinic Administrator and needing some guidance on a situation that they had encountered here. The situation was that a CMA was getting a Menveo vaccine ready to administer and noticed that it was the last vial of the gray cap but that there were 2 vials of the orange caps left, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. She administered the correct dose with the two correct vials, but he/she was needing to see if there was a recommendation since we are not able to identify the patient that received only the gray top vial of the 4 other doses. The reporter had a report that identified the 4 patients.